Skip to Main Content

Paper Details

<i>De novo</i> design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8.
bioRxiv
0
2023
Arg, Arg-Gly-Asp, RGD, RGD integrins, anti-v6 antibody BG00011, bleomycin, cancer, fibrosis, integrin binding proteins, integrin heterodimer, integrin proteins, integrins v6, lung fibrosis, mouse, patients, v6, v8
Author NameAffiliation
John C KraftDepartment of Biochemistry and Institute for Protein Design, University of Washington
Lauren CarterDepartment of Biochemistry and Institute for Protein Design, University of Washington
Frank DiMaioDepartment of Biochemistry and Institute for Protein Design, University of Washington
Frank DiMaioDepartment of Biochemistry and Institute for Protein Design, University of Washington
Melody G CampbellFred Hutchinson Cancer Center
David BakerDepartment of Biochemistry and Institute for Protein Design, University of Washington
David BakerHoward Hughes Medical Institute, University of Washington
David BakerDepartment of Biochemistry and Institute for Protein Design, University of Washington
David BakerHoward Hughes Medical Institute, University of Washington
  • 1 - 9

Datasets